Home Carboxys 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-

7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-

CAS No.:
127045-41-4
Catalog Number:
AG01DQAI
Molecular Formula:
C16H15FN2O4
Molecular Weight:
318.2997
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
25mg
98%(HPLC)
In Stock USA
United States
$85
- +
100mg
98%(HPLC)
In Stock USA
United States
$225
- +
1g
98%(HPLC)
In Stock USA
United States
$711
- +
Product Description
Catalog Number:
AG01DQAI
Chemical Name:
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
CAS Number:
127045-41-4
Molecular Formula:
C16H15FN2O4
Molecular Weight:
318.2997
MDL Number:
MFCD26387508
IUPAC Name:
(2S)-6-(1-aminocyclopropyl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
InChI:
InChI=1S/C16H15FN2O4/c1-7-6-23-14-11(16(18)2-3-16)10(17)4-8-12(14)19(7)5-9(13(8)20)15(21)22/h4-5,7H,2-3,6,18H2,1H3,(H,21,22)/t7-/m0/s1
InChI Key:
XAGMUUZPGZWTRP-ZETCQYMHSA-N
SMILES:
OC(=O)c1cn2[C@@H](C)COc3c2c(c1=O)cc(c3C1(N)CC1)F
UNII:
4CZ1R38NDI
Properties
Complexity:
603  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
318.102g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
318.304g/mol
Monoisotopic Mass:
318.102g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
92.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.8  
Literature
Title Journal
Single-dose pharmacokinetics and dose proportionality of intravenous pazufloxacin mesilate in healthy Korean volunteers. Expert opinion on drug metabolism & toxicology 20120801
Efficacy of prophylactic single-dose therapy using fluoroquinolone for prostate brachytherapy. Japanese journal of radiology 20120501
Generalized fixed drug eruption caused by pazufloxacin. Acta dermato-venereologica 20110901
In vivo efficacy of sivelestat in combination with pazufloxacin against Legionella pneumonia. Experimental lung research 20101001
Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100601
[Clinical pharmacokinetics/pharmacodynamics study on pazufloxacin methanesulphonate injection]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20090701
Enhanced separation of seven quinolones by capillary electrophoresis with silica nanoparticles as additive. Talanta 20090315
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents. Drug metabolism and pharmacokinetics 20090101
Spectroscopic studies on the interaction of pazufloxacin with calf thymus DNA. Journal of photochemistry and photobiology. B, Biology 20081211
[Evaluation of clinical effectiveness of Pazufloxacin Mesilate in acute exacerbation of chronic respiratory diseases]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20081001
Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives. Bioorganic & medicinal chemistry 20071201
A rapid CE-potential gradient detection method for determination of quinolones. Electrophoresis 20071101
[Effectiveness of switch therapy for peritonitis]. The Japanese journal of antibiotics 20070801
Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate. International journal of biological macromolecules 20070601
Influence of cefoperazone and azithromycin on the pharmacokinetics of pazufloxacin in rats. European journal of drug metabolism and pharmacokinetics 20070101
Chiral separation of four fluoroquinolone compounds using capillary electrophoresis with hydroxypropyl-beta-cyclodextrin as chiral selector. Journal of chromatography. A 20061020
[Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs]. The Japanese journal of antibiotics 20060401
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa]. The Japanese journal of antibiotics 20060201
In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species. The Journal of antimicrobial chemotherapy 20051201
Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. The Journal of antimicrobial chemotherapy 20050701
Efficacy of pazufloxacin mesilate in Legionnaires' disease: a case report and in vitro study of the isolate. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20050601
[A travel abroad-associated case of Legionella pneumonia diagnosed by urinary antigen detection test]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20050401
[Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)]. The Japanese journal of antibiotics 20050201
Possible involvement of P-glycoprotein in renal excretion of pazufloxacin in rats. European journal of pharmacology 20041006
[Effect of pazufloxacin mesilate, a new quinolone antibacterial agent, for intravenous use on QT interval]. The Japanese journal of antibiotics 20040801
[Pharmacological properties and expected clinical role of an injectable new quinolone antibiotic, pazufloxacin mesilate]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20030801
[Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesilate]. The Japanese journal of antibiotics 20030201
Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats. The Journal of pharmacy and pharmacology 20020901
[In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone]. The Japanese journal of antibiotics 20020801
[In vitro combination effect of pazufloxacin with various antibiotics against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus]. The Japanese journal of antibiotics 20020801
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies]. The Japanese journal of antibiotics 20020601
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration]. The Japanese journal of antibiotics 20020601
Effect of pazufloxacin mesilate on the serum concentration of theophylline. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301
[In vitro antimycobacterial activity of a new quinolone, T-3761]. Kekkaku : [Tuberculosis] 19950201
Properties